Merit Medical Systems (MMSI) Research & Development (2010 - 2026)

Merit Medical Systems (MMSI) has 17 years of Research & Development data on file, last reported at $22.6 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development rose 0.58% year-over-year to $22.6 million; the trailing twelve-month figure through Mar 2026 stood at $97.5 million (up 10.2% YoY), and the FY2025 full-year result was $97.4 million, up 11.3% from the prior year.
• Research & Development declined to $22.6 million in Q1 2026, from $26.5 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $26.5 million in Q4 2025 to a low of $17.4 million in Q1 2022.
• A 5-year average of $21.5 million and a median of $21.3 million in 2023 frame the typical range for Research & Development.
• Across the five-year window, Research & Development gained 0.15% in 2022 and climbed 22.59% in 2023, its largest moves.
• Tracing MMSI's Research & Development over 5 years: stood at $20.4 million in 2022, then climbed by 5.89% to $21.6 million in 2023, then gained by 16.43% to $25.2 million in 2024, then climbed by 5.35% to $26.5 million in 2025, then retreated by 14.81% to $22.6 million in 2026.
• Business Quant data shows MMSI's Research & Development at $22.6 million in Q1 2026, $26.5 million in Q4 2025, and $24.0 million in Q3 2025.